1 Al-Ofi, E. A. & Anumba, D. O. Ligands of toll-like receptors 2/4 differentially alter markers of inflammation, adhesion and angiogenesis by monocytes from women with pre-eclampsia in co-culture with endothelial cells. J Reprod Immunol121, 26-33, doi:10.1016/j.jri.2017.05.002 (2017).
2 Gao, Q. et al. Upregulation of P53 promoted G1 arrest and apoptosis in human umbilical cord vein endothelial cells from preeclampsia. J Hypertens34, 1380-1388, doi:10.1097/HJH.0000000000000944 (2016).
3 Yetik-Anacak, G. & Catravas, J. D. Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vascul Pharmacol45, 268-276, doi:10.1016/j.vph.2006.08.002 (2006).
4 Konukoglu, D. & Uzun, H. Endothelial Dysfunction and Hypertension. Advances in experimental medicine and biology956, 511-540, doi:10.1007/5584_2016_90 (2017).
5 Brown, D. Preeclampsia, hypertension, and a possible treatment for preeclampsia. Med Hypotheses140, 109669, doi:10.1016/j.mehy.2020.109669 (2020).
6 Amaral, L. M., Cunningham, M. W., Jr., Cornelius, D. C. & LaMarca, B. Preeclampsia: long-term consequences for vascular health. Vasc Health Risk Manag11, 403-415, doi:10.2147/VHRM.S64798 (2015).
7 Lip, S. V. et al. Early-onset preeclampsia, plasma microRNAs, and endothelial cell function. Am J Obstet Gynecol222, 497 e491-497 e412, doi:10.1016/j.ajog.2019.11.1286 (2020).
8 Karatza, A. A. & Dimitriou, G. Preeclampsia emerging as a novel risk factor for cardiovascular disease in the offspring. Curr Pediatr Rev, doi:10.2174/1573396316666191224092405 (2019).
9 Ding, D. C., Shyu, W. C. & Lin, S. Z. Mesenchymal stem cells. Cell transplantation20, 5-14, doi:10.3727/096368910X (2011).
10 Samsonraj, R. M. et al. Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine. Stem cells translational medicine6, 2173-2185, doi:10.1002/sctm.17-0129 (2017).
11 Lv, F. J., Tuan, R. S., Cheung, K. M. & Leung, V. Y. Concise review: the surface markers and identity of human mesenchymal stem cells. Stem cells32, 1408-1419, doi:10.1002/stem.1681 (2014).
12 Fu, X. et al. Mesenchymal Stem Cell Migration and Tissue Repair. Cells8, doi:10.3390/cells8080784 (2019).
13 Keshtkar, S., Azarpira, N. & Ghahremani, M. H. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem cell research & therapy9, 63, doi:10.1186/s13287-018-0791-7 (2018).
14 Anasiz, Y., Ozgul, R. K. & Uckan-Cetinkaya, D. A New Chapter for Mesenchymal Stem Cells: Decellularized Extracellular Matrices. Stem Cell Rev Rep13, 587-597, doi:10.1007/s12015-017-9757-x (2017).
15 Ceserani, V. et al. Angiogenic and anti-inflammatory properties of micro-fragmented fat tissue and its derived mesenchymal stromal cells. Vasc Cell8, 3, doi:10.1186/s13221-016-0037-3 (2016).
16 Babajani, A., Soltani, P., Jamshidi, E., Farjoo, M. H. & Niknejad, H. Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer. Front Bioeng Biotechnol8, 748, doi:10.3389/fbioe.2020.00748 (2020).
17 Carvalho, A. É. S., Sousa, M. R. R., Alencar-Silva, T., Carvalho, J. L. & Saldanha-Araujo, F. Mesenchymal stem cells immunomodulation: The road to IFN-γ licensing and the path ahead. Cytokine & growth factor reviews47, 32-42, doi:10.1016/j.cytogfr.2019.05.006 (2019).
18 Meirelles Lda, S., Fontes, A. M., Covas, D. T. & Caplan, A. I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine & growth factor reviews20, 419-427, doi:10.1016/j.cytogfr.2009.10.002 (2009).
19 Wang, Z. et al. Transplantation of human villous trophoblasts preserves cardiac function in mice with acute myocardial infarction. Journal of cellular and molecular medicine21, 2432-2440, doi:10.1111/jcmm.13165 (2017).
20 Hsuan, Y. C., Lin, C. H., Chang, C. P. & Lin, M. T. Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke. Brain Behav6, e00526, doi:10.1002/brb3.526 (2016).
21 Ding, H. et al. Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response. Cell Mol Immunol14, 693-701, doi:10.1038/cmi.2015.99 (2017).
22 Cunningham, C. J., Redondo-Castro, E. & Allan, S. M. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J Cereb Blood Flow Metab38, 1276-1292, doi:10.1177/0271678X18776802 (2018).
23 Chu, Y. et al. Human omental adipose-derived mesenchymal stem cells enhance autophagy in ovarian carcinoma cells through the STAT3 signalling pathway. Cellular signalling69, 109549, doi:10.1016/j.cellsig.2020.109549 (2020).
24 Gentile, M. T., Pastorino, O., Bifulco, M. & Colucci-D'Amato, L. HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis. Journal of visualized experiments : JoVE, doi:10.3791/58591 (2019).
25 Heo, S. H. & Cho, J. Y. ELK3 suppresses angiogenesis by inhibiting the transcriptional activity of ETS-1 on MT1-MMP. Int J Biol Sci10, 438-447, doi:10.7150/ijbs.8095 (2014).
26 Yu, H., Littlewood, T. & Bennett, M. Akt isoforms in vascular disease. Vascul Pharmacol71, 57-64, doi:10.1016/j.vph.2015.03.003 (2015).
27 Song, M. & Finley, S. D. ERK and Akt exhibit distinct signaling responses following stimulation by pro-angiogenic factors. Cell communication and signaling : CCS18, 114, doi:10.1186/s12964-020-00595-w (2020).
28 Shiojima, I. & Walsh, K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circulation research90, 1243-1250, doi:10.1161/01.res.0000022200.71892.9f (2002).
29 Sandvoss, M., Potthast, A. B., von Versen-Hoynck, F. & Das, A. M. HELLP Syndrome. Reprod Sci24, 568-574, doi:10.1177/1933719116667216 (2017).
30 van Rijn, B. B. et al. Postpartum Circulating Markers of Inflammation and the Systemic Acute-Phase Response After Early-Onset Preeclampsia. Hypertension67, 404-414, doi:10.1161/HYPERTENSIONAHA.115.06455 (2016).
31 Pecher, S. J., Potthast, A. B., von Versen-Hoynck, F. & Das, A. M. Impact of Short-Term Hypoxia on Sirtuins as Regulatory Elements in HUVECs. J Clin Med9, doi:10.3390/jcm9082604 (2020).
32 Li, M., Qian, L., Yu, J. & Zou, Y. Interleukin-35 inhibits human umbilical vein endothelial cell injury induced by sera from pre-eclampsia patients by up-regulating S100A8 protein expression. Hypertens Pregnancy39, 126-138, doi:10.1080/10641955.2020.1744000 (2020).
33 Abumaree, M. H. et al. Preconditioning human natural killer cells with chorionic villous mesenchymal stem cells stimulates their expression of inflammatory and anti-tumor molecules. Stem cell research & therapy10, doi:10.1186/s13287-019-1153-9 (2019).
34 Basmaeil, Y. S. et al. Human chorionic villous mesenchymal stem/stromal cells protect endothelial cells from injury induced by high level of glucose. Stem cell research & therapy9, doi:10.1186/s13287-018-0984-0 (2018).
35 MacDonald, E. S. & Barrett, J. G. The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses. Front Vet Sci6, 507, doi:10.3389/fvets.2019.00507 (2019).
36 Rodriguez-Fuentes, D. E. et al. Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review. Archives of medical research, doi:10.1016/j.arcmed.2020.08.006 (2020).
37 Du, W. et al. VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity. Stem cell research & therapy7, 49, doi:10.1186/s13287-016-0297-0 (2016).
38 Ma, J. et al. Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord, and chorionic plate under serum-free condition. Stem cell research & therapy10, 19, doi:10.1186/s13287-018-1104-x (2019).
39 Kim, Y. H., Park, T. C., Lee, G. & Shin, J. C. Gene expression pattern of human chorion-derived mesenchymal stem cells during adipogenic differentiation. Yonsei Med J53, 1036-1044, doi:10.3349/ymj.2012.53.5.1036 (2012).
40 Saleh, M. et al. Perspective of placenta derived mesenchymal stem cells in acute liver failure. Cell Biosci10, 71, doi:10.1186/s13578-020-00433-z (2020).
41 Evangelista, M., Soncini, M. & Parolini, O. Placenta-derived stem cells: new hope for cell therapy? Cytotechnology58, 33-42, doi:10.1007/s10616-008-9162-z (2008).
42 Rempel, S., Stanek, W. K. & Slotboom, D. J. ECF-Type ATP-Binding Cassette Transporters. Annu Rev Biochem88, 551-576, doi:10.1146/annurev-biochem-013118-111705 (2019).
43 Tachikawa, M. et al. Gene expression of A6-like subgroup of ATP-binding cassette transporters in mouse brain parenchyma and microvessels. Anat Sci Int93, 456-463, doi:10.1007/s12565-018-0435-0 (2018).
44 Imperio, G. E. et al. Gestational age-dependent gene expression profiling of ATP-binding cassette transporters in the healthy human placenta. Journal of cellular and molecular medicine23, 610-618, doi:10.1111/jcmm.13966 (2019).
45 Tachikawa, M., Toki, H., Tomi, M. & Hosoya, K. Gene expression profiles of ATP-binding cassette transporter A and C subfamilies in mouse retinal vascular endothelial cells. Microvasc Res75, 68-72, doi:10.1016/j.mvr.2007.05.002 (2008).
46 Zhang, X. et al. Coculture of mesenchymal stem cells and endothelial cells enhances host tissue integration and epidermis maturation through AKT activation in gelatin methacryloyl hydrogel-based skin model. Acta Biomater59, 317-326, doi:10.1016/j.actbio.2017.07.001 (2017).
47 Bing-Hua Jiang, L.-Z. L. AKT Signaling in Regulating Angiogenesis. Current Cancer Drug Targets8, 19 - 26 (2008).
48 Weng, L., Enomoto, A., Ishida-Takagishi, M., Asai, N. & Takahashi, M. Girding for migratory cues: roles of the Akt substrate Girdin in cancer progression and angiogenesis. Cancer science101, 836-842, doi:10.1111/j.1349-7006.2010.01487.x (2010).
49 Karar, J. & Maity, A. PI3K/AKT/mTOR Pathway in Angiogenesis. Front Mol Neurosci4, 51, doi:10.3389/fnmol.2011.00051 (2011).
50 Chen, Y. et al. Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K-->AKT-->GSK3beta-->AM signaling. Oncogene36, 2879-2888, doi:10.1038/onc.2016.442 (2017).